A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

NCT03665285 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors
Lung Cancer
Breast Cancer
Head and Neck Squamous Cell Carcinoma
Endometrial Cancer
Melanoma
CRC
Urothelial Carcinoma
Cholangiocarcinoma

Interventions

DRUG: NC318

Sponsor

NextCure, Inc.